Expert Insights & Commentary
BLOG
The South Florida Venture Tech Chronicle Blog goes beyond the headlines.
Here, founders, investors, and industry experts share their perspectives on emerging technologies, investment strategies, and the challenges shaping our innovation ecosystem.
Expect thought leadership, data-driven opinions, and long-form features that deepen understanding of where tech is headed next.
Boca Raton's INmune Bio Partners with Quantum Computing Inc. to Advance Alzheimer's Drug Research
Boca Raton-based INmune Bio is partnering with Quantum Computing Inc. to explore how quantum optimization and artificial intelligence could unlock new opportunities in Alzheimer's drug research, advancing the intersection of biotechnology, emerging technology, and South Florida innovation.
Boca Raton Biotech Firm INmune Bio Advances Novel Alzheimer's Therapy with FDA Fast Track Designation
Boca Raton-based INmune Bio has received FDA Fast Track designation for XPro™, an experimental Alzheimer's therapy that targets neuroinflammation rather than amyloid plaques. The milestone highlights both a promising new approach to treating Alzheimer's disease and South Florida's growing role in biotechnology innovation.
MedTech World North America Signals a New Era for Florida’s Healthcare Innovation Economy
The inaugural MedTech World North America conference brought more than 600 healthcare innovators, investors, and executives from 26 countries to West Palm Beach, spotlighting Florida’s growing influence in MedTech, biosciences, AI, and healthcare innovation. The event showcased how global conferences are helping reshape South Florida into a rising hub for healthcare technology, investment, and economic growth.
GBI Biomanufacturing Expands in South Florida, Signaling a Turning Point for the Region’s Life Sciences Infrastructure
GBI Biomanufacturing is entering a major new growth phase in South Florida, marked by a 40,000-square-foot facility expansion, a $26 million infrastructure investment, and a strategic ramp-up in stem cell manufacturing capacity toward one million doses annually. With new President Jesse McCool at the helm and recognition as BioFlorida’s 2025 Manufacturer of the Year, the company is strengthening its role as a key biomanufacturing anchor in the region’s evolving life sciences ecosystem. Its expanded cGMP facility integrates advanced biologics production, fill-finish capabilities, and end-to-end process development, positioning GBI at the center of South Florida’s shift from emerging biotech market to operational manufacturing hub.
BioFlorida’s Launchpad Initiative Signals a New Era for Florida’s Life Sciences Economy
Florida’s life sciences ecosystem is entering a new phase of growth with the launch of the BioFlorida BioPitch Launchpad Initiative, a statewide effort designed to connect university innovation and regional pitch competitions directly to investors. By creating a structured pathway to the BioFlorida Annual Innovation Conference 2026 in Orlando, the initiative is helping transform promising research into investable companies and strengthening Florida’s position as a rising national leader in biotechnology and life sciences innovation.